Influenza – Talk Bio

Actionable Insights Powered by AI

Moderna Shares Fall as Company Withdraws Flu/COVID-19 Combination Vaccine Application

2 weeks ago talkbio0Tagged Biologics License Application, Clinical Trials, COVID19 (disease), Effectiveness, Influenza, Moderna, mRNA-1083, Prices, United States Food and Drug Administration, Vaccines, Vaccines, Combined

Moderna; mRNA-1083; combination vaccine; flu; COVID-19; FDA; Biologics License Application; vaccine efficacy; clinical trial; share price

Pfizer Unveils PfizerForAll, a Direct-to-Consumer Platform for Migraine, Flu, and COVID-19 Products

9 months ago talkbio0Tagged COVID19 (disease), Direct-to-Consumer, Influenza, Migraine Disorders, PfizerForAll, Prescription Services, Savings Programs, Scheduled - procedure status, Telemedicine, Vaccination

PfizerForAll, Direct-to-Consumer, Migraine, Flu, COVID-19, Telehealth, Prescription Services, Vaccination Scheduling, Savings Programs